Which Way Are These Stocks Heading? Fortress Investment Group LLC (FIG), Southcross Energy Partners LP (SXE) and Pacific Biosciences of California (PACB)

Posted by Saimoon April 1, 2015 0 Comment 501 views


New York, NY – GDP INSIDER  –  04/01/2015.

This article discusses three companies: Fortress Investment Group LLC (NYSE:FIG), Southcross Energy Partners LP (NYSE:SXE) and Pacific Biosciences of California (NASDAQ:PACB)

Fortress Investment Group LLC (NYSE:FIG) continued to climb yesterday with the stock gaining $0.20 to close the day at a closing price of $8.07, a2.54% increase in value from its precious closing price with 0.877 million shares changing hands compared to its 30 day average trading volume of 0.786 million. Fortress Investment Group LLC has been doing well over the past six months with the stock gaining 17.30%, compared to the S&P 500 which is up only 4.85% for the same period. With EPS of $0.47 and a one year price target of $9.17, the stock has a good long term investment potential.

Do Fortress Investment Group LLC’s Current Trend Indicate Its Future Direction? Lear More About Company’s Trajectory With Our Free FIG Analysis.

Southcross Energy Partners LP (NYSE:SXE) gained $0.23 as the stock jumped 1.67% to finish the day at a closing price of $14.00 with 0.695 million shares changing hands compared to its 30 day average trading volume of 0.139 million. Southcross Energy Partners LP is holding 7.96% above its 50 day moving average of $12.99 but below its 200 day moving average of $17.40. With RSI value of 57.89 and one year price target estimate of $15.38, the stock has plenty of upside potential making it a hold than buy at this time.

Is Now The Time To Invest In Southcross Energy Partners LP? Find Our More In Our Free SXE Analysis.

Pacific Biosciences of California (NASDAQ:PACB) reverse its upward trend yesterday with the stock declining 5.81% or $0.36 to close the day at a closing price of $5.84 on high trading volume of 1.88 million, compared to its 30 day average trading volume of 0.663 million. The US-based biological research tools developer and marketer has been outperforming the S&P 500 for the past 6 months, with the stock up 18.94% compared to the index which has gained only 4.85% over the same period. With quarterly revenue growth (yoy ) fo 85.70% and price target estimate of $8.67, Pacific Biosciences of California is a hold.

What Does The Future Hold For Pacific Biosciences of California? Read Our Free PACB Analysis To Know More.

About UltimateStockAlerts

UltimateStockAlerts.com provides investors and traders with trading strategies via text message and email. To obtain text message stock alerts service text the word ULTIMATE to 555888 from your cell phone.

UltimateStockAlerts continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.

Disclosure:  UltimateStockAlerts is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit www.UltimateStockAlerts.com website, for complete risks and disclosures.


Write Your Comment